{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-115692","form_type":"8-K","ticker":"AHCO","cik":"0001725255","company_name":"AdaptHealth Corp.","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.895775+00:00","generated_at":"2026-06-22T04:06:50.035645+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AdaptHealth Q3 revenue $756.5M (+15.8% YoY); net income drops 72% to $16.1M; FY guidance narrowed","bullets":["Q3 2022 net revenue $756.5M vs $653.3M in Q3 2021, +15.8%.","Net income $16.1M ($0.11 diluted EPS) vs $58.1M ($0.20) in Q3 2021.","Adjusted EBITDA $160.2M, +2.5% YoY; cash from ops $107.0M vs $27.1M.","FY2022 guidance updated: revenue $2.950B-$3.010B; adjusted EBITDA $620M-$650M.","Repurchased $10.6M of common stock during quarter under existing authorization."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-115692","json":"https://secwatch.observer/filing/0001104659-22-115692.json","markdown":"https://secwatch.observer/filing/0001104659-22-115692.md","text":"https://secwatch.observer/filing/0001104659-22-115692.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725255/000110465922115692/0001104659-22-115692-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725255/000110465922115692/tm2229847d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T04:06:50.035645+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d0c13a1ac800f8d617704471c67f8437c6776e77","claim":"AdaptHealth Corp. reported financial results for three and nine months ended September 30, 2022.","evidence_excerpt":"On November 8, 2022, AdaptHealth Corp. (the “Company”) issued a press release (the “Press Release”) announcing financial results for the three and nine months ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1725255/000110465922115692/0001104659-22-115692-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}